ArticleAmerican journal of translational research2026
A comparative study on the efficacy of rituximab combined with tacrolimus and methylprednisolone in the treatment of patients with moderate-high risk idiopathic membranous nephropathy.
Weiwei Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.